[Pneumococcal Vaccination Coverage Rates (VCRs) Among Persons with Vaccine-Relevant Underlying Conditions and Persons Aged 60 Years and Older - An Analysis of Secondary Data from the Statutory Health Insurance (SHI) System].

Sarah Mihm, Jörg Schelling, Regine Wölle, Andreas Suck, Dennis Häckl, Thomas Weinke, Timo Böllinger
Author Information
  1. Sarah Mihm: MSD SHARP & DOHME GmbH, München, Deutschland.
  2. Jörg Schelling: LMU, Medizinische Fakultät, München, Deutschland.
  3. Regine Wölle: MSD SHARP & DOHME GmbH, München, Deutschland.
  4. Andreas Suck: MSD SHARP & DOHME GmbH, München, Deutschland.
  5. Dennis Häckl: WIG2 GmbH, Leipzig, Deutschland.
  6. Thomas Weinke: Klinikum Ernst von Bergmann, Klinik für Gastroenterologie und Infektiologie, Potsdam, Deutschland.
  7. Timo Böllinger: MSD SHARP & DOHME GmbH, München, Deutschland.

Abstract

BACKGROUND: In addition to standard vaccination for patients aged 60 and older, the Standing Committee on Vaccination (STIKO) recommends immunization against pneumococci for anyone at increased risk, including patients with chronic vaccine-relevant underlying conditions. In Germany, the Robert Koch Institute (RKI) regularly publishes vaccination coverage rates (VCRs) for these patient groups, without stratifying by other parameters. This study examines VCRs of patients with underlying chronic diseases, stratified by disease groups and entities, the re-vaccination rate, and VCRs in patients aged 60 years and older.
METHODS: This descriptive retrospective cohort study is based on a sample of about 4 million SHI-insured patients aged 16 years and older for the years 2014 to 2019, from the Institute for Applied Health Research (InGef) database. The sample is representative of age and sex distribution in the German population.
RESULTS: Extrapolated to the total SHI-population, the overall pneumococcal VCR in patients aged 60 years and older was 45.9 % (of n= InGef standard vaccination cohort: 1 009 763). Among all at-risk patients aged 16 years and older with chronic underlying diseases, only 17.1 % had received an indicated vaccination (InGef indicated vaccination cohort: 1 379 680). Stratified by disease entity, those with underlying pulmonary emphysema had the highest VCR, at 39.0 % (of n= 28 121). Of those who received a vaccination due to an underlying chronic disease, only 23.9 % were re-vaccinated after 6 years (InGef re-vaccination cohort: 12 328). Across all vaccination cohorts, VCRs increased with age.
DISCUSSION: The recommendations made by STIKO for pneumococcal vaccination based on age or an underlying chronic condition are not being implemented adequately in Germany. Although STIKO explicitly recommends vaccination from 60 years of age, the 60 to 64-year-old age group had a strikingly low VCR (13.0 % of n=268 862). Fewer than one in five patients aged 16 years and older with an underlying chronic condition had received the recommended indicated vaccination. To adequately prevent potential disease, higher vaccination rates should be targeted. This could probably be achieved through more stringent vaccination management, appropriate software solutions with vaccination reminders, monetary incentives for achieving higher vaccination rates and documentation of vaccination status in disease management programs.

References

  1. Internist (Berl). 2021 Aug;62(8):807-815 [PMID: 34251467]
  2. BMC Infect Dis. 2022 Sep 28;22(1):753 [PMID: 36171549]
  3. Wkly Epidemiol Rec. 2007 Mar 23;82(12):93-104 [PMID: 17380597]
  4. Public Health. 2022 May;206:57-62 [PMID: 35378455]
  5. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):433-439 [PMID: 30820616]
  6. Pharmacoepidemiol Drug Saf. 2016 Jan;25(1):106-9 [PMID: 26530279]

MeSH Term

Humans
Middle Aged
Aged
Vaccination Coverage
Retrospective Studies
Vaccination
Vaccines
Chronic Disease
Insurance, Health

Chemicals

Vaccines

Word Cloud

Created with Highcharts 10.0.0vaccinationpatientsyearsunderlyingaged60olderchronicVCRsdiseaseage%InGefSTIKOrates16VCRcohort:1receivedindicatedstandardVaccinationrecommendsincreasedGermanyInstitutegroupsstudydiseasesre-vaccinationbasedsampleHealthpneumococcal9n=Among0conditionadequatelyhighermanagementPersonsBACKGROUND:additionStandingCommitteeimmunizationpneumococcianyoneriskincludingvaccine-relevantconditionsRobertKochRKIregularlypublishescoveragepatientwithoutstratifyingparametersexaminesstratifiedentitiesrateMETHODS:descriptiveretrospectivecohort4millionSHI-insured20142019AppliedResearchdatabaserepresentativesexdistributionGermanpopulationRESULTS:ExtrapolatedtotalSHI-populationoverall45009763at-risk17379680Stratifiedentitypulmonaryemphysemahighest3928121due23re-vaccinated612328AcrosscohortsDISCUSSION:recommendationsmadeimplementedAlthoughexplicitly64-year-oldgroupstrikinglylow13n=268862Feweronefiverecommendedpreventpotentialtargetedprobablyachievedstringentappropriatesoftwaresolutionsremindersmonetaryincentivesachievingdocumentationstatusprograms[PneumococcalCoverageRatesVaccine-RelevantUnderlyingConditionsAgedYearsOlder-AnalysisSecondaryDataStatutoryInsuranceSHISystem]

Similar Articles

Cited By (1)